A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates

Heart

Volumn 100, Issue 6, 2014, Pages 473-478

  Munkholm Larsen, Stine ^a,b   Wan, Benjamin ^a   Tian, David H ^a   Kearney, Katherine ^a   Rahnavardi, Mohammad ^a   Dixen, Ulrik ^b   Køber, Lars ^c   Alfieri, Ottavio ^d   Yan, Tristan D ^a,e  

^a The Collaborative Research   (Australia)

^b HVIDOVRE HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DISEASE SEVERITY; EUROSCORE; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; FUNCTIONAL STATUS; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CLIP; IMPLANTATION; LENGTH OF STAY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PERCUTANEOUS EDGE TO EDGE MITRAL VALVE REPAIR; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCIBILITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW;

CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROSTHESIS DESIGN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; WORLD HEALTH;

EID: 84896720705     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304049     Document Type: Article

References (62)

1. Lung B, Baron G, Tornos P, et al. Valvular heart disease in the community: a European experience. Curr Probl Cardiol 2007;32:609-61. (Pubitemid 350001365)
2. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-23. (Pubitemid 26382502)
3. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65. (Pubitemid 47355974)
4. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81. (Pubitemid 35470109)
5. Maisano F, Vigano G, Blasio A, et al. Surgical isolated edge-to-edge mitral valve repair without annuloplasty: clinical proof of the principle for an endovascular approach. EuroIntervention 2006;2:181-6.
6. Fucci C, Sandrelli L, Pardini A, et al. Improved results with mitral valve repair using new surgical techniques. Eur J Cardio-thoracic Surg 1995;9:621-26.
7. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol 2005;46:2134-40. (Pubitemid 41713603)
8. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
9. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. CRD Report 4. 2nd edn. York: University of York, 2001.
10. Alegria-Barrero E, Chan PH, Paulo M, et al. Edge-to-edge percutaneous repair of severe mitral regurgitation-state-of-the-art for Mitraclip(R) implantation. Circ J 2012;76:801-8.
11. Rogers JH, Franzen O. Percutaneous edge-to-edge MitraClip therapy in the management of mitral regurgitation. Eur Heart J 2011;32:2350-7.
12. Altiok E, Hamada S, Brehmer K, et al. Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography. Circ Cardiovasc Imaging 2012;5:748-55.
13. Conradi L, Treede H, Rudolph V, et al. Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes. Eur J Cardio-thoracic Surg 2013. Published Online First: Epub Date. doi:10.1093/ejcts/ezt036
14. Baldus S, Schillinger W, Franzen O, et al. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 2012;14:1050-5.
15. Treede H, Schirmer J, Rudolph V, et al. A heart team's perspective on interventional mitral valve repair: percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients. J Thorac Cardiovasc Surg 2012;143:78-84.
16. Rudolph V, Knap M, Franzen O, et al. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol 2011;58:2190-5.
17. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
18. Pleger ST, Mereles D, Schulz-Schonhagen M, et al. Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol 2011;108:1478-82.
19. Schillinger W, Athanasiou T, Weicken N, et al. Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 2011;13:1331-9.
20. Paranskaya L, D'Ancona G, Bozdag-Turan I, et al. Residual mitral valve regurgitation after percutaneous mitral valve repair with the mitraclip(R) system is a risk factor for adverse one-year outcome. Catheter Cardiovasc Interv 2013;81:609-17.
21. Kische S, D'Ancona G, Paranskaya L, et al. Staged total percutaneous treatment of aortic valve pathology and mitral regurgitation: institutional experience. Catheter Cardiovasc Interv 2013. Published Online First: Epub Date. doi:10.1002/ccd.24809
22. Divchev D, Kische S, Paranskaya L, et al. In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip(R) device. J Interv Cardiol 2012;25:180-9.
23. Paranskaya L, D'Ancona G, Bozdag-Turan I, et al. Percutaneous vs surgical repair of mitral valve regurgitation: single institution early and midterm outcomes. Can J Cardiol 2013;29:452-9.
24. Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.
25. Grasso C, Capodanno D, Scandura S, et al. One-and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol 2013;111:1482-7.
26. Scandura S, Ussia GP, Capranzano P, et al. Left cardiac chambers reverse remodeling after percutaneous mitral valve repair with the MitraClip system. J Am Soc Echocardiogr 2012;25:1099-105.
27. Ussia GP, Cammalleri V, Sarkar K, et al. Quality of life following percutaneous mitral valve repair with the MitraClip system. Int J Cardiol 2012;155:194-200.
28. Taramasso M, Denti P, Buzzatti N, et al. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience. Eur J Cardio-thoracic Surg 2012;42:920-6.
29. Ihlemann N, Franzen O, Jorgensen E, et al. Promising results after percutaneous mitral valve repair. Dan Med Bull 2011;58:A4299.
30. Chan PH, She HL, Alegria-Barrero E, et al. Real-world experience of MitraClip for treatment of severe mitral regurgitation. Circ J 2012;76:2488-93.
31. Van den Branden BJ, Swaans MJ, Post MC, et al. Percutaneous edge-to-edge mitral valve repair in high-surgical-risk patients: do we hit the target? JACC. Cardiovasc Interv 2012;5:105-11.
32. Gaemperli O, Moccetti M, Surder D, et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012;98:126-32.
33. Gaemperli O, Biaggi P, Gugelmann R, et al. Real-time left ventricular pressure-volume loops during percutaneous mitral valve repair with the MitraClip system. Circulation 2013;127:1018-27.
34. Surder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 2013;99:1034-40.
35. Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-9.
36. Franzen O, van der Heyden J, Baldus S, et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76.
37. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
38. Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr 2007; 20:1131-40. (Pubitemid 47487496)
39. Foster E, Wasserman HS, Gray W, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100:1577-83. (Pubitemid 350050867)
40. Herrmann HC, Rohatgi S, Wasserman HS, et al. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv 2006;68:821-8. (Pubitemid 44847084)
41. Biner S, Siegel RJ, Feldman T, et al. Acute effect of percutaneous MitraClip therapy in patients with haemodynamic decompensation. Eur J Heart Fail 2012; 14:939-45.
42. Siegel RJ, Biner S, Rafique AM, et al. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011;57:1658-65.
43. Argenziano M, Skipper E, Heimansohn D, et al. Surgical revision after percutaneous mitral repair with the MitraClip device. Ann Thorac Surg 2010;89:72-80; discussion p 80.
44. Herrmann HC, Gertz ZM, Silvestry FE, et al. Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol 2012;59:1312-19.
45. Armstrong E, Rogers J, Swan C, et al. Abstracts of the 35th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions. May 9-12, 2012. Las Vegas, Nevada, USA. Catheter Cardiovasc Interv 2012;79(Suppl 1):S1-10.
46. Herrmann HC, Kar S, Siegel R, et al. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention 2009;4:437-42.
47. Glower D, Ailawadi G, Argenziano M, et al. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg 2012;143(4 Suppl):S60-3.
48. Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012;59:130-9.
49. Condado JA, Acquatella H, Rodriguez L, et al. Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case. Catheter Cardiovasc Interv 2006;67:323-5. (Pubitemid 43235173)
50. Cleland JG, Coletta AP, Freemantle N, et al. Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II. Eur J Heart Fail 2011;13:805-8.
51. Shih HH, Kang PL, Pan JY, et al. Performance of European system for cardiac operative risk evaluation in Veterans General Hospital Kaohsiung cardiac surgery. J Chin Med Assoc 2011;74:115-20.
52. Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009;87:1431-7; discussion 37-9.
53. Lim S, Kar S, Fail P, et al. The Everest II High Surgical Risk Cohort: effectiveness of transcatheter reduction of significant mitral regurgitation in high surgical risk patients. J Am Coll Cardiol 2013;61:E1958.
54. Maisano F, Franzen O, Baldus S, et al. Access Europe: a post market study of the mitraclip system for the treatment of significant mitral regurgitation (MR) in Europe: analysis of outcomes at 6-months. J Am Coll Cardiol 2012;59(13s1):E2001.
55. Schillinger W, Hünlich M, Baldus S, et al. Acute outcomes after MitraClip® therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention 2013;9:84-90.
56. Soni LK, Argenziano M. Percutaneous treatment of mitral regurgitation: current status and future directions. Semin Thorac Cardiovasc Surg 2011;23:268-70.
57. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-18. (Pubitemid 34701385)
58. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000;139:596-608. (Pubitemid 30207784)
59. ClinicalTrials.gov Identifier: NCT01626079. http://clinicaltrials.gov/ ct2/show/ NCT01626079
60. ClinicalTrials.gov Identifier: NCT01772108. http://clinicaltrials.gov/ ct2/show/ NCT01772108
61. Members ATF, Vahanian A, Alfieri O, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
62. Members ATF, McMurray JJV, Adamopoulos S, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.